Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 77KA5 | — |
possible incomplete dose administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete dose administered in unspecified number of patients who received Men B NVS (Bexsero) (batch number 77KA5, expiry date 30-NOV-2027) for prophylaxis. This case was associated with a product complaint. On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incomplete dose administered (Verbatim: possible incomplete dose administration). The outcome of the incomplete dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-MAY-2025 The Vaccine Administration Facility is the same as Primary Reporter A registered nurse asked if she could give a lot number of Bexsero to avoid receiving it in a future order given that she had issues trying to expel the air bubble, like losing a significant amount of the vaccine fluid. The reporter mentioned that, approximately 10 patients receive it after trying to expel the bubble between April and May 2025 which led to incomplete dose administered. The adverse event details were taken but she had no data of exactly which patients received it.